Thus, in this study, various lymphocyte subpopulations expressing immunosuppressive receptors and IL-6 were selected as predictors of efficacy in hepatocellular carcinoma patients receiving immunotherapy. The gene discussed is IL6; the disease is hepatocellular carcinoma.